The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals.
Dr. Marty Makary, the FDA’s commissioner, said in a statement that the “approval represents a significant milestone for ...
The FDA is expected to decide on treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity.
Months after Trump administration officials promoted a medication as a possible treatment for autism, the FDA is expanding ...
The FDA announced a new approved use for the drug leucovorin, which Trump has touted as a treatment for autism. But the ...
Add Yahoo as a preferred source to see more of our stories on Google. The GLP-1 pill also set the stage for a year of other groundbreaking approvals, including an oral Wegovy competitor, a potential ...
The Food and Drug Administration on March 10 changed the approval for a version of the prescription drug leucovorin to include people with a very rare genetic condition. FDA Commissioner Dr. Marty ...
Merck's animal health unit got approval for a drug to treat and control certain ticks in dogs from the Food and Drug Administration. Merck said Wednesday its Bravecto Quantum is now approved to treat ...
Stocktwits on MSN
Wall Street says Johnson and Johnson’s FDA-approved psoriasis drug should create 'significant value' for Protagonist Therapeutics
Icotyde was jointly discovered by Protagonist and Johnson & Johnson but it will now be commercialized by Johnson & Johnson alone under a license and collaboration agreement established in 2017. ・H.C.
Although FDA Commissioner Marty Makary promised “an exciting treatment” for autism, what the agency delivered was a label ...
This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. When Sarepta Therapeutics revealed this month that a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results